Clinical Trials
71 trialsActive Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
ОС26
Military Medical Clinical Center of the Southern Region, Ukraine
Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer
City of Hope Medical Center
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
LAP100
NRG Oncology
XAI-EGC
The First Affiliated Hospital of Soochow University
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University
An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori
Fudan University
EULAT
Centre Paul Strauss
The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota
Fudan University
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
Shanghai Tongji Hospital, Tongji University School of Medicine
Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases
Fudan University
RPx
Replimune, Inc.
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Children's Oncology Group
MICROPAC
Herlev Hospital
ALFAOMEGA
IFOM ETS - The AIRC Institute of Molecular Oncology
ALFAOMEGA-R
IFOM ETS - The AIRC Institute of Molecular Oncology
Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma
Sichuan University
Observational Registry Data on GIST Patients
National Health Research Institutes, Taiwan
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
NRG Oncology
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Tempus AI
ATTENUATION
Centre Leon Berard
Intestinal Flora Differences Between Colorectal Cancer Patients and Healthy Individuals
Hansung University
GASPAR
Latin American Cooperative Oncology Group
The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
Peking Union Medical College Hospital
Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
Fujian Medical University
Artificially Intelligent Model for Accurate Detection of HCC
Zhejiang University
ANCHOR
AIDS Malignancy Consortium
China Early Esophageal Cancer Cohort
Changhai Hospital
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
Zhejiang Cancer Hospital
Prospective Observational Cohort Study
Chinese PLA General Hospital
ADAGE
Federation Francophone de Cancerologie Digestive
Metronomic Capecitabine in Stage III Gastric Cancer
Fudan University
Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma
Zhejiang University
Significance of Benign Lymph Node Enlargement in Colorectal Cancer
Peking University Third Hospital
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer
Zhujiang Hospital
Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application
Shanghai Zhongshan Hospital
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
Geneplus-Beijing Co. Ltd.
BMA and Dynamic Nomogram for Survival Prediction in Patients With CRC
Cabrini Health
Pancreatic Surgery in Elderly Patients
Rigshospitalet, Denmark
Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient
Peking Union Medical College Hospital
A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients
Jinling Hospital, China
PILOT
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Cross-sectional Follow-up on Digestive and Social Functions of SPN
Peking Union Medical College Hospital
Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
RACE-GB
Sanjay Gandhi Postgraduate Institute of Medical Sciences
PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery
Fudan University
HPV-SAVE
University Health Network, Toronto